What is RxFunction?
Headquartered in Eden Prairie, Minnesota, RxFunction operates as a specialized medical device developer focused on the intersection of biomechanics and patient safety. Since its inception in 2010, the company has dedicated its research and development efforts to creating innovative solutions that mitigate fall risks, thereby enhancing mobility and confidence for vulnerable patient populations. The firm's core value proposition lies in its ability to translate complex physiological data into actionable medical hardware, positioning it as a key player in the geriatric and rehabilitative care markets. By prioritizing clinical efficacy and user-centric design, RxFunction has successfully navigated the transition from early-stage development to a mature enterprise-level entity, consistently demonstrating the viability of its balance-enhancing platforms.
How much funding has RxFunction raised?
RxFunction has raised a total of $11.6M across 3 funding rounds:
Private Equity
$4M
Series A
$7.5M
Debt
$150K
Private Equity (2017): $4M, investors not publicly disclosed
Series A (2018): $7.5M, investors not publicly disclosed
Debt (2020): $150K supported by PPP
Key Investors in RxFunction
PPP
Public-Private Partnership
Undisclosed Investor
An institutional backer focused on long-term value creation and strategic scaling within the medical device and healthcare technology sectors.
Undisclosed Investor
A specialized investment firm providing early-stage and growth-stage capital to high-potential companies in the life sciences and medical technology industries.
What's next for RxFunction?
With the recent influx of capital, RxFunction is well-positioned to scale its operational footprint and accelerate the commercialization of its next-generation mobility devices. The strategic focus will likely shift toward expanding clinical trials and strengthening distribution channels to reach a broader demographic of patients at risk of falling. As the company moves into this next phase of growth, the integration of advanced data analytics into its existing hardware suite remains a primary objective. This evolution will not only solidify its competitive advantage in the medtech landscape but also provide the necessary infrastructure to support long-term sustainability and market penetration in an increasingly digital-first healthcare environment.
See full RxFunction company page
